Derek M Yellon PhD, DSc (UK), DSc (SA), FRCP (Hon), FACC, FESC, FAHA is Professor of Molecular & Cellular Cardiology at University College London & Director of the Hatter Cardiovascular Institute at UCL.
He was Programme Director (Cardiology-Diabetes) for the NIHR-UCLH BRC from 2013-2017 and past Vice-President of the British Cardiovascular Society and Chairman of the Cellular Biology Working Group of the European Society of Cardiology. In 1994 he was awarded a DSc for his “substantial contribution to the knowledge of cardiovascular disease and treatment”. In 2013 he was awarded a second DSc (honorius causa) from the University of Cape Town in recognition of his “distinguished basic and clinical research in the mechanisms underlying myocardial protection”.
He is also Hon Professor in the Department of Medicine at the University of Cape Town; as well as the University of South Alabama, USA, and North China Coal Medical University.
He is on editorial boards of many Cardiovascular journals and has published in excess of 550 papers (H factor 95) and edited 23 books. He runs a translational research Institute at UCL; his main research area being; myocardial protection, pathophysiology of cardioprotection in setting of diabetes, ischaemia-reperfusion injury, and myocardial conditioning in both the basic and clinical arena.
